According to the Statement of Facts, five former TDBNA employees provided material
assistance, often in return for a fee, to a second money laundering scheme. In violation of TDBNAs policies and their training, these five former employees at TDBNA branches in New Jersey and Florida opened accounts and issued dozens of ATM
cards for the money laundering networks, which these networks used to transmit funds from the United States to Colombia through high volume ATM withdrawals. Through the accounts the five former employees opened, the money laundering networks
laundered approximately $39 million through TDBNA. The Pleading Entities did not identify the role the five former employees played until law enforcement arrested one of the employees in October 2023.
According to the Statement of Facts, from March 2021 through March 2023, another money laundering network that purported to be involved in the
wholesale diamond, gold, and jewelry business maintained accounts for at least five shell companies at TDBNA and used those accounts to move approximately $123 million in illicit funds through TDBNA. Since their account openings in 2021, TDBNA
knew that these shell companies were connected because they shared the same account signatories. TDBNA did not file a Suspicious Activity Report (SAR) on this money laundering network until law enforcement alerted TDBNA to its conduct in
April 2022. By that time, the accounts had been open for over 13 months and had been used to transfer nearly $120 million through TDBNA.
Each of the Pleading Entities has agreed to resolve the action brought by MLARS and USAO-DNJ through a
plea agreement presented to the District Court on October 10, 2024 (the Plea Agreements). Under the Plea Agreements, each Pleading Entity agreed to enter a plea of guilty to the charge set out in the Information. In
addition, each Pleading Entity has made an admission of guilt to the District Court. Sentencing occurred November 7, and the District Court entered a judgment against each Pleading Entity that requires remedies that are the same as those
set forth in the Plea Agreements.
According to the Plea Agreements, each of the Pleading Entities agrees:
(1) to abide by all terms and obligations of the Plea Agreement;
(2) that in the event that, during the term of the Plea Agreements (i.e., the period from October 10, 2024 to five years from the
date the independent compliance monitor is retained by the Pleading Entities), the Pleading Entity undertakes any change in corporate form, including if it sells, merges, or transfers business operations that are material to its consolidated
operations, or to the operations of any subsidiaries, branches, or affiliates involved in the conduct described in the Statement of Facts, as they exist as of the date of the Plea Agreements, whether such transaction is structured as a sale, asset
sale, merger, transfer, or other change in corporate form, it shall include in any contract for sale, merger, transfer, or other change in corporate form a provision binding the purchaser, or any successor in interest thereto, to the obligations
described in the Plea Agreements;
(3) to continue to cooperate fully with MLARS and the USAO-DNJ
in any and all matters relating to the conduct, individuals, and entities described in the Plea Agreements and the Statement of Facts as well as any other conduct, individuals, and entities under investigation by MLARS or the USAO-DNJ at any time during the term of the Plea Agreements, until the later of the date upon which all investigations and prosecutions arising out of such conduct are concluded, or the end of the term of the Plea
Agreements;
6 of 31